Global Oncology Molecular Diagnostics Market Share

Statistics for the 2023 & 2024 Global Oncology Molecular Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Global Oncology Molecular Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Oncology Molecular Diagnostics Industry

The oncology molecular diagnostics market is highly fragmented, with the presence of several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the market are Danaher Corporation (Cepheid), Veracyte Inc, Abbott Laboratories, F-Hoffmann La-Roche Ltd, and Thermo Fisher Scientific Inc.

Oncology Molecular Diagnostics Market Leaders

  1. Abbott Laboratories

  2. F-Hoffmann La-Roche Ltd

  3. Thermo Fisher Scientific Inc.

  4. Danaher Corporation (Cepheid)

  5. Veracyte Inc.

*Disclaimer: Major Players sorted in no particular order

Market Concentration-OMD market.png

Oncology Molecular Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)